13.07.2015 Views

chitosan and plga microspheres as drug delivery ... - UniCA Eprints

chitosan and plga microspheres as drug delivery ... - UniCA Eprints

chitosan and plga microspheres as drug delivery ... - UniCA Eprints

SHOW MORE
SHOW LESS

You also want an ePaper? Increase the reach of your titles

YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.

7. RFP Loaded PLGA Coated Chitosan Microspheres Obtained by WSD Methodcoating particles. The highest cellular viability w<strong>as</strong> found for particles more concentrated in<strong>chitosan</strong> while the lowest for the uncoated PLGA particles. Therefore <strong>chitosan</strong> reducedtoxicity effects of plain PLGA <strong>as</strong> a consequence of its deposition on the surface of PLGA<strong>microspheres</strong>.10080Viability60402000,1 0,25 0,5 EmptyNo Chit 0,1% Chit 0,25% Chit 0,5% Chit 0,75% Chit RFP SolutionFigure 7.8: Viability Studies of RFP-Loaded PLGA Coated Chitosan Microsferes withA549 Cells7.3. ConclusionPLGA <strong>microspheres</strong> coated with mucoadhesive polymer were successfully prepared by theemulsion solvent diffusion methods in water (WSD). The surface coating of <strong>microspheres</strong>with <strong>chitosan</strong>, w<strong>as</strong> confirmed by the change in zeta potential. The excellent mucoadhesionproperties of <strong>chitosan</strong>-coated PLGA <strong>microspheres</strong> were proved by their significant adsorptionto the mucin solution mainly due to the electrostatic attraction between the amino groups of<strong>chitosan</strong> <strong>and</strong> the negatively charged mucin. The <strong>chitosan</strong>-coated PLGA <strong>microspheres</strong>, whichimproved the RFP loading, were applied to improve the pulmonary <strong>delivery</strong> of the <strong>drug</strong> bynebulization. The particle diameter of the aqueous dispersion of the <strong>microspheres</strong> w<strong>as</strong> animportant factor to enclose the particles in the aerosolized aqueous droplets produced with thenebulizer.The elimination rate of <strong>chitosan</strong>-modified <strong>microspheres</strong> from the lungs can decre<strong>as</strong>esignificantly due to the mucoadhesive property after pulmonary administration compared tothat of the unmodified <strong>microspheres</strong>. Furthermore, it w<strong>as</strong> supposed that <strong>chitosan</strong> on thesurface of the <strong>microspheres</strong> enhances the <strong>drug</strong> absorption by opening the intercellular tightjunctions in the lung epithelium. These findings demonstrated that the <strong>chitosan</strong>-modified116

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!